SCHEMBL30540071

SCHEMBL30540071

CC(C)(C)OC(=O)N1C2CCC1CC1(CC(N3CCOCC3)C1)C2.CC(C)(C)OC(=O)N1C2CCC1CC1(CC(N3CCOCC3)C1)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 2/20 0.49
▸ CHRM2 P08172 1/20 0.49
▸ CHRM3 P20309 1/20 0.49
▸ USP2 O75604 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ RECQL P46063 1/20 0.46
▸ PREP P48147 4/20 0.41
▸ HSD11B1 P28845 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.36
▸ CCR2 P41597 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.34
▸ PIK3CA P42336 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3R2 O00459 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ PIK3R5 Q8WYR1 1/20 0.33
▸ PIK3R3 Q92569 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25364103 1.00 CHRM1 (0.49) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL18235300 0.85 CHRM1 (0.60) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL30567071 0.83 CHRM2 (0.48) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL26064977 0.83 CHRM2 (0.48) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL31554879 0.82 CHRM1 (0.45) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL30540043 0.81 USP2 (0.59) USP2SMN1; SMN2RECQLCCR2GPR119
SCHEMBL25366279 0.81 USP2 (0.59) USP2SMN1; SMN2RECQLCCR2GPR119
SCHEMBL30539365 0.80 CHRM2 (0.66) CHRM1CHRM2CHRM3USP2SMN1; SMN2
SCHEMBL30539374 0.79 CHRM2 (0.55) CHRM1CHRM2CHRM3RECQLPREP
SCHEMBL25365341 0.78 HRH3 (0.39) SMN1; SMN2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479384-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF Biogen MA Inc. (US) 2024-12-25 — — EP disclosed
WO-2023154499-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-17 — — WO disclosed
Send feedback